Your browser doesn't support javascript.
A real-world ten-week follow-up of the COVID outbreak in an outpatient drug clinic in Salamanca (Spain).
Aguilar, Lourdes; Vicente-Hernández, Begoña; Remón-Gallo, Diego; García-Ullán, Llanyra; Valriberas-Herrero, Isabel; Maciá-Casas, Ana; Pérez-Madruga, Ana; Garzón, Maria Ángeles; Álvarez-Navares, Ana; Roncero, Carlos.
  • Aguilar L; Psychiatry Service, University of Salamanca Health Care Complex, Paseo de San Vicente 58-182, 37007 Salamanca, Spain; Psychiatric Unit, School of Medicine, University of Salamanca (Spain), Alfonso X El Sabio Street, 37007 Salamanca, Spain; Institute of Biomedicine, University of Salamanca, Paseo de
  • Vicente-Hernández B; Psychiatry Service, University of Salamanca Health Care Complex, Paseo de San Vicente 58-182, 37007 Salamanca, Spain; Institute of Biomedicine, University of Salamanca, Paseo de San Vicente, 58-182, 37007 Salamanca, Spain.
  • Remón-Gallo D; Psychiatric Unit, School of Medicine, University of Salamanca (Spain), Alfonso X El Sabio Street, 37007 Salamanca, Spain; Institute of Biomedicine, University of Salamanca, Paseo de San Vicente, 58-182, 37007 Salamanca, Spain.
  • García-Ullán L; Psychiatry Service, University of Salamanca Health Care Complex, Paseo de San Vicente 58-182, 37007 Salamanca, Spain; Psychiatric Unit, School of Medicine, University of Salamanca (Spain), Alfonso X El Sabio Street, 37007 Salamanca, Spain; Institute of Biomedicine, University of Salamanca, Paseo de
  • Valriberas-Herrero I; Psychiatry Service, University of Salamanca Health Care Complex, Paseo de San Vicente 58-182, 37007 Salamanca, Spain; Institute of Biomedicine, University of Salamanca, Paseo de San Vicente, 58-182, 37007 Salamanca, Spain.
  • Maciá-Casas A; Psychiatry Service, University of Salamanca Health Care Complex, Paseo de San Vicente 58-182, 37007 Salamanca, Spain; Institute of Biomedicine, University of Salamanca, Paseo de San Vicente, 58-182, 37007 Salamanca, Spain.
  • Pérez-Madruga A; Psychiatry Service, University of Salamanca Health Care Complex, Paseo de San Vicente 58-182, 37007 Salamanca, Spain; Institute of Biomedicine, University of Salamanca, Paseo de San Vicente, 58-182, 37007 Salamanca, Spain.
  • Garzón MÁ; Psychiatry Service, University of Salamanca Health Care Complex, Paseo de San Vicente 58-182, 37007 Salamanca, Spain; Institute of Biomedicine, University of Salamanca, Paseo de San Vicente, 58-182, 37007 Salamanca, Spain.
  • Álvarez-Navares A; Psychiatry Service, University of Salamanca Health Care Complex, Paseo de San Vicente 58-182, 37007 Salamanca, Spain; Institute of Biomedicine, University of Salamanca, Paseo de San Vicente, 58-182, 37007 Salamanca, Spain.
  • Roncero C; Psychiatry Service, University of Salamanca Health Care Complex, Paseo de San Vicente 58-182, 37007 Salamanca, Spain; Psychiatric Unit, School of Medicine, University of Salamanca (Spain), Alfonso X El Sabio Street, 37007 Salamanca, Spain; Institute of Biomedicine, University of Salamanca, Paseo de
J Subst Abuse Treat ; 125: 108303, 2021 06.
Article in English | MEDLINE | ID: covidwho-1078047
ABSTRACT

OBJECTIVE:

To compare over ten weeks the number of relapses, hospital admissions, calls made, admissions to therapeutic communities, face-to-face visits, treatment adjustment, number of injectables administered, and number of emergencies attended due to emotional and behavioral alterations and/or substance use disorder, and to describe and quantify social emergencies in an outpatient drug clinic (ODC) in Salamanca (Spain) from March 16, 2020, to May 22, 2020.

METHODS:

This is an ecological study of the COVID pandemic over ten weeks. The study examines the set of alcohol or other drug-dependent or dual disorder patients in the population of Salamanca, Spain. The measurements were professionals; calls made; percentage of successful calls; face-to-face visits; first visits made; reviews made; techniques; injectable treatments; other treatments; evolution; relapses. The ODC includes about 375 new patients each year and another 650 other patients annually.

RESULTS:

The study found the number of relapses to be greater in the last five weeks of the 10-week study period. Patients' psychopathological instability also increased, and face-to-face visits were necessary. The most frequent psychopathology that required face-to-face intervention was depressive disorder. The number of interventions with patients increased. In parallel, social workers' efforts were greater after the seventh week. There was a decrease in response to calls. Throughout this time, the ODC attended to patients who needed to be treated for the first time.

CONCLUSIONS:

Confinement due to the coronavirus pandemic generated maladaptive emotional responses and other behaviors, such as excessive alcohol consumption. The number of face-to-face consultations, admissions, and referrals to therapeutic communities increased. Patients under stress and in social isolation resorted more often to substance use. The ODC had to adopt a flexible approach to evaluate patients with more serious problems, by using face-to-face assessments.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Outpatients / Disease Outbreaks / Substance Abuse Treatment Centers / Substance-Related Disorders / COVID-19 Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study Limits: Humans Country/Region as subject: Europa Language: English Journal: J Subst Abuse Treat Journal subject: Substance-Related Disorders Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Outpatients / Disease Outbreaks / Substance Abuse Treatment Centers / Substance-Related Disorders / COVID-19 Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study Limits: Humans Country/Region as subject: Europa Language: English Journal: J Subst Abuse Treat Journal subject: Substance-Related Disorders Year: 2021 Document Type: Article